Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Demographic and Clinical Characteristics of Patients Treated With Lecanemab Stratified by Amyloid-Related Imaging Abnormality Status 2026-08-13
  2. Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis 2024-02-01
  3. Detection of β-amyloid positivity in Alzheimer's Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers 2021-02-02

Studies

4 studies carry this tag.

Date range

2013 to 2026

Top journals

  • Alzheimer disease and associated disorders 1
  • Brain communications 1
  • Cureus 1
  • The Lancet. Neurology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Demographic and Clinical Characteristics of Patients Treated With Lecanemab Stratified by Amyloid-Related Imaging Abnormality Status

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. Cureus 2026-08-13 Treatments

    In this real-world cohort of patients treated with lecanemab, ARIAs occurred in nearly one-third of patients.

  2. Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis

    ✓ Peer-reviewed alzhub usefulness score 83 out of 100. The Lancet. Neurology 2024-02-01 Brain scans and imaging

    The disorder has been associated with underlying neuropathological features of Alzheimer's disease, but large-scale biomarker and neuropathological studies are scarce.

  3. Detection of β-amyloid positivity in Alzheimer's Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Brain communications 2021-02-02 Biomarkers

    Our results confirm plasma β-amyloid 42 /β-amyloid 40 as a robust biomarker of brain β-amyloid-positivity (area under curve, 0.80-0.87).

  4. The demographic and medical correlates of plasma aβ40 and aβ42

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Alzheimer disease and associated disorders 2013-07-01 Biomarkers

    Plasma amyloid β-42 (Aβ42) and Aβ42/Aβ40 are increasingly recognized as biomarkers for dementia, with low levels indicating increased risk.

All topic tags with their study counts